Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) T.ATE

Alternate Symbol(s):  ATBPF

Healthcare
Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

TSX:ATE - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > If 2021 is any indication ...
View:
Post by MrMugsy on Jun 24, 2022 7:30pm

If 2021 is any indication ...

Going into the last week of June !

It was on the last Monday of June 2021 that we received the financials and an update.
It never seems to work out the same ... but ... conditions are similar in 2022 as they were in 2021 - no financing news - no other news getting in the way - so - I'm betting on a repeat for financials in the final week of June. 

Good thing I'm not putting any cash on that one.

Add to that to the comments made at Bloom Burton and the timing seems "about" right.

Have a good weekend Longs !
Comment by davgro on Jun 24, 2022 9:18pm
The following is an excerpt from today's Thomson Reuters StockReports+ for ATE.  They have listed the next expected report date as June 29th, 2022.
Comment by MrMugsy on Jun 24, 2022 9:33pm
Perfect - thanks Davgro ! --------------------------------------------------------
Antibe Therapeutics Inc(Pre-Merger)